Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,746 | 598 | 99.1% |
| Education | $99.99 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,940 | 100 | $0 (2024) |
| Novo Nordisk Inc | $1,794 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,018 | 51 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $624.23 | 40 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $520.13 | 34 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $506.26 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $384.00 | 21 | $0 (2024) |
| EISAI INC. | $372.77 | 18 | $0 (2022) |
| Merck Sharp & Dohme LLC | $359.37 | 22 | $0 (2023) |
| Astellas Pharma US Inc | $354.86 | 13 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,266 | 61 | PFIZER INC. ($326.62) |
| 2023 | $1,224 | 62 | PFIZER INC. ($328.66) |
| 2022 | $1,135 | 59 | PFIZER INC. ($361.56) |
| 2021 | $1,410 | 73 | Novo Nordisk Inc ($268.56) |
| 2020 | $748.38 | 40 | Novo Nordisk Inc ($203.36) |
| 2019 | $1,383 | 81 | PFIZER INC. ($238.78) |
| 2018 | $1,653 | 96 | PFIZER INC. ($331.33) |
| 2017 | $2,028 | 127 | Novo Nordisk Inc ($322.87) |
All Payment Transactions
599 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Obesity | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: PAIN | ||||||
| 10/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.64 | General |
| 10/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $1.00 | General |
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Obesity | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $33.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $34.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Vaccines | ||||||
| 08/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: DIABETES | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Obesity | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: NEUROLOGY | ||||||
| 06/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Obesity | ||||||
| 06/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 788 | 903 | $112,841 | $52,812 |
| 2022 | 15 | 764 | 913 | $113,476 | $55,142 |
| 2021 | 10 | 365 | 464 | $80,325 | $47,904 |
| 2020 | 11 | 320 | 389 | $69,836 | $33,310 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 128 | 133 | $43,225 | $16,925 | 39.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 75 | 75 | $11,250 | $10,038 | 89.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 87 | $19,575 | $9,156 | 46.8% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 29 | 29 | $15,631 | $4,350 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 49 | $6,125 | $3,172 | 51.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $3,300 | $3,097 | 93.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 144 | 198 | $2,985 | $1,663 | 55.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 125 | 135 | $4,995 | $1,509 | 30.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 19 | 19 | $1,425 | $1,397 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $600.00 | $588.00 | 98.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 19 | 19 | $475.00 | $336.11 | 70.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $330.00 | $323.40 | 98.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 112 | 117 | $2,925 | $257.40 | 8.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 129 | 148 | $45,250 | $20,921 | 46.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 90 | $19,125 | $9,064 | 47.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 63 | 63 | $9,256 | $8,669 | 93.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 64 | $8,000 | $4,540 | 56.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 19 | 19 | $10,241 | $2,872 | 28.0% |
| 93268 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | Office | 2022 | 11 | 11 | $2,564 | $1,637 | 63.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 100 | 120 | $4,440 | $1,432 | 32.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 12 | 12 | $4,380 | $1,290 | 29.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 18 | 18 | $1,350 | $1,265 | 93.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 18 | $1,450 | $837.12 | 57.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $750.00 | $735.00 | 98.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $715.00 | $700.70 | 98.0% |
About Dr. David Zich, MD
Dr. David Zich, MD is a Emergency Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013022565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Zich, MD has received a total of $10,846 in payments from pharmaceutical and medical device companies, with $1,266 received in 2024. These payments were reported across 599 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($10,746).
As a Medicare-enrolled provider, Zich has provided services to 2,237 Medicare beneficiaries, totaling 2,669 services with total Medicare billing of $189,167. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Internal Medicine
- Location Chicago, IL
- Active Since 08/21/2006
- Last Updated 02/05/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1013022565
Products in Payments
- ELIQUIS (Drug) $1,915
- FARXIGA (Drug) $563.11
- Ozempic (Drug) $487.49
- JARDIANCE (Drug) $420.89
- Dayvigo (Drug) $372.77
- Wegovy (Drug) $368.52
- XARELTO (Drug) $343.24
- TRINTELLIX (Drug) $321.13
- Victoza (Drug) $304.19
- Saxenda (Drug) $275.99
- NURTEC ODT (Drug) $272.86
- XIFAXAN (Drug) $267.31
- CHANTIX (Drug) $216.06
- BELSOMRA (Drug) $205.36
- Trintellix (Drug) $200.51
- MYRBETRIQ (Drug) $150.61
- SHINGRIX (Biological) $141.33
- SYMBICORT (Drug) $136.96
- Edarbi (Drug) $132.95
- Prolia (Biological) $129.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Chicago
Dr. Barbara Bellar, M.d., J.d., Ma., Mph, M.D., J.D., MA., MPH
Emergency Medicine — Payments: $471,425
Dr. Christopher Ross, Md, MD
Emergency Medicine — Payments: $338,465
Janet Lin, M.d, M.D
Emergency Medicine — Payments: $118,644
Michael Kurz
Emergency Medicine — Payments: $114,691
Yanina Purim Shem Tov, M.d, M.D
Emergency Medicine — Payments: $90,220
Pratik Mehta, Md, MD
Emergency Medicine — Payments: $74,561